Epstein-Barr Virus Reprograms B Cells for Cancer Development

Strategic Insights -

Scientists at The Wistar Institute have made a significant discovery about the mechanisms by which the Epstein-Barr virus (EBV) reprograms B cells to facilitate cancer development. EBV, which infects over 90% of the world's population, typically causes mild or no symptoms but can lead to serious diseases, including multiple cancers and autoimmune conditions like multiple sclerosis. The research, published in Nucleic Acids Research, reveals that a key protein from EBV, called EBNA-LP, hijacks the function of host cells to activate regions of the genome that usually shouldn't be activated, making infected B cells appear younger and more plastic.

Key Takeaways:

  • The Epstein-Barr virus protein EBNA-LP has the ability to hijack the function of host cells to activate regions of the genome that usually shouldn't be activated, making infected B cells appear younger and more plastic.
  • This process converts mature, differentiated B cells into a more naive, stem-cell-like state, increasing cell plasticity and making infected cells more adaptable and responsive to signals that promote cancerous growth.
  • The research provides a mechanistic understanding that could lead to EBV-specific therapies, which are currently lacking, and reveals a vulnerability that might be exploited by EBV-related cancer treatments.
  • EBV's EBNA-LP protein interacts with YY1, a protein in B cells that normally helps organize the DNA's three-dimensional structure, and this interaction affects how the genome is folded.
  • The fact that the virus has evolved multiple proteins to target the same cellular process signals that this mechanism is critical for infection success.
  • The study suggests that similar genome-restructuring mechanisms might occur in non-EBV cancers through genetic mutations, creating the possibility for new, even more broadly applicable therapeutic approaches.
  • EBV-specific therapies might be developed by targeting the virus's hijacking of the host cellular process.
  • The Wistar Institute's research also implies that viruses have a tendency to use existing tools and mechanisms in the host cells to their own advantage.

Statistics:

  • Over 90% of the world's population is infected with Epstein-Barr virus.
  • The virus causes mild or no symptoms in most cases but can lead to serious diseases, including multiple cancers and autoimmune conditions like multiple sclerosis.
  • EBNA-LP protein has a unique function in interacting with YY1 to affect how the genome is folded, making restricted genomic regions accessible when they shouldn't be.
  • The study used HiChIP (Hi-C combined with chromatin immunoprecipitation) mapping technique to show that EBNA-LP has a unique function and interacts with YY1.
  • The research is supported by National Health Institutes (NIH) grants, including R01AI130209, R01AI182056, R01AI153508, P01 CA269043, and P30 CA010815.

Sources:

  • Tempera, I., et al. "EBNA Leader Protein Orchestrates Chromatin Architecture Remodeling During Epstein-Barr Virus-Induced B Cell Transformation." Nucleic Acids Research, 2025, Online publication.
  • The Wistar Institute. "Scientists at The Wistar Institute Have Discovered How a Key Protein from the Epstein-Barr Virus Rewires the DNA Structure to Promote Cancer Development." The Wistar Institute, July 9, 2019.